請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35844完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳秀熙 | |
| dc.contributor.author | Cheng-Hui Lin | en |
| dc.contributor.author | 林姃慧 | zh_TW |
| dc.date.accessioned | 2021-06-13T07:13:14Z | - |
| dc.date.available | 2005-08-03 | |
| dc.date.copyright | 2005-08-03 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-26 | |
| dc.identifier.citation | Reference
Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. New England Journal of Medicine 1994;330:1710-6. American Thoracic Society, Centers for Disease Control and Prevention: Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K. Mycobacterium tuberculosis Beijing genotype emerging in Viet Nam. Emerging Infectious Diseases 2000;6:302-5. Bai KJ, Yu MC, Suo J, et al: Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis. J Formos Med Assoc 1998;97:278-82. Bandera A, Gori A, Catozzi L, Degli Esposti A, Marchetti G, Molteni C, et al. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. Journal of Clinical Microbiology 2000;39:2213-8. Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644-50. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends in Microbiology 2002;10:45-52. Borgdorff MW, Floyd K, Broekmans JF. Interventions to reduce tuberculosis mortality and transmission in low-and middle-income countries. Bull World Health Organ. 2002;80:217-227. Borgdorff MW, Nagelkerke N, van Soolingen D, de Haas PE, Veen J, van Embden JD, et al. Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting. American Journal of Epidemiology 1998;147:187-95. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Afonso O, Martin C, et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. American Journal of Respiratory and Critical Care Medicine. 2000;163:717-20. CDC. Trends in tuberculosis – United States, 2004. MMWR. 2005;54:245-249. Center for Disease Control (Taiwan): Tuberculosis Annual Report, 2001. Center for Disease Control (Taiwan): Tuberculosis Annual Report, 2000. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2004;169:1103-1109. Chang CE. Trends of primary drug resistance of Mycobacterium tuberculosis patients in recent 10 years in Taiwan. In: Taiwan Provincial Health Department. Collected reports of medical research 1985; pp 137-147. Chiang IH, Yu MC, Bai KJ, et al: Drug resistance patterns of tuberculosis in Taiwan. J Formos Med Assoc 1998;97:581-3. Chiang CY, Hsu CJ, Huang RM, et al. Antituberculosis drug resistance among retreatment tuberculosis patients in a referral center in Taipei. J Formos Med Assoc 2004;103:411-415. Chou Sung-Ching. A epidemiological study on tuberculosis disease: What we learn from the Taiwan Provincial Chronic Disease Control Bureau (TPCDCB) cohort. 1998. Chronic Disease Control Bureau (Taiwan): Tuberculosis Statistics, 1999. Chronic Disease Control Bureau, Department of Health: TB statistics-1997. Taipei: Chronic Disease Control Bureau, 1998. Cohen T, Murray M. Incident tuberculosis among recent US immigrants and exogenous reinfection. Emerging Infectious Diseases. 2005;11:725-728 Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009- 1021. Crofton J, Chaulet P, Maher D: Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997. Daley CL, Smal PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment length polymorphisms. New England Journal of Medicine 1992;326:231-5. Doroudchi M, Kremer K, Basiri EA, Kadivar MR, van Soolingen D, Ghaderi AA, et al. IS6110-RFLP and spoligotyping of Mycobacterium tuberculosis isolates in Iran. Scandinavian Journal of Infectious Diseases 2000;32:663-8. Drobniewski F, Eltringham I, Graham C, et al. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax. 2002;57:810-816. Dye C, Williams BG, Espinal MA, et al. Erasing the world’s slow stain: strategies to beat multidrug-resistant tuberculosis. Science. 2002;295:2042-2046. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths rate globally. JAMA. 2005;293:2767-2775. Edline BR, Tokars JL, Grieco MH, et al. An outbreak of multi-drug resistant tuberculosis among hospitalization patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-1521. Enarson DA: Tuberculosis in aboriginals in Canada. Int J Tuberc Lung Dis 1998;2:S16-22. Espinal M, Laszlo A, Simonsen L, et al: Global trends in resistance to antituberculosis drugs. N Engl J Med 2001;344:1294-303. Espinal MA, Kim SJ, Suarez PG, et al: Standard short-course chemotherapy for drug-resistant tuberculosis. Treatment outcomes in 6 countries. JAMA 2000;283:2537-45. Feng Z, Castillo-Chavez C, Capurro AF. A model of tuberculosis with exogenous reinfection. Theoretical Population Biology 2000;57:235-247. Fifty-third World Health Assembly: Stop Tuberculosis Initiative, Report by the Director General. A53/5, 5 May 2000. Geneva, Switzerland: World Health Organization; 2000. Frieden T, ed. Toman’s Tuberculosis: Case Detection, Treatment and Monitoring. 2nd ed. Geneva, Switzerland: World Health Organization; 2004. Genewein A, Telenti A, Bernasconi C, Mordasini C, Weiss S, Maurer AM, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993;342:841-4. Godfrey-Faussett P, Mortimer PR, Jenkins PA, Stoker NG. Evidence of transmission of tuberculosis by DNA fingerprinting. BMJ 1992;305:221-3. Godfrey-Faussett P, Mortimer PR, Jenkins PA, Stoker NG. Outbreak of tuberculosis in a church. Chest 1995;107:447-52. Godfrey-Faussett P, Sonnenberg P, Shearer SC, Bruce MC, Mee C, Morris L, et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet 2000;356:1066-71. Granich RM, Oh P, Lewis B, et al. Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA. 2005;293:2732-2739. Grzybowski S, Styblo K, Dorken E. Tuberculosis in Eskimos. Tubercle. 1976;57(suppl):1-58. Hsing CT, Han FC. Clinical observation of drug resistant pulmonary tuberculosis. Chinese Med J 1964;11:226-233. Holmes CB, Hausler H, Nunn P. A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis 1998;2:96-104. Hudelson P. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Tuberc Lung Dis 1996;7:391-400. Jou R, Chen HY, Chiang CY, et al. Genetic diversity of multidrug resistant Mycobacterium tuberculosis isolates and identification of 11 Novel rpoB alleles in Taiwan. Journal of Clinical Biology 2005;43:1390-1394. Khan K, Muennig P, Pharm MB, et al. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med. 2002;347:1850-1859. Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Incidence of pulmonary tuberculosis in Korean civilservants. Tuberc Lung Dis. 1995;76:534-539. Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. New England Journal of Medicine 1995;333:222-7. Lee JJ, Lee CN, Suo J, Chiang IH, Lin CB, Lin TY, et al. Drug resistance of Mycobacterium tuberculosis in eastern Taiwan. Tzu Chi Med J 2003;15:229-34. Leung CC, Li T, Lam TH, et al: Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med. 2004;170(9):1027-33. Lin TM, Chao SL, Luan HW, et al: An analytical study on the mortality and prevalence rates of pulmonary tuberculosis in the aboriginal area in Taiwan. J Formos Med Assoc 1980;80:359-68. Liu CE, Chen CH, Hsiao JH, et al. Drug resistance of Mycobacterium tuberculosis complex in central Taiwan. J Microbio Immunol Infect 2004;37:295-300. Lo CF. A continuing survey of primary drug resistant tuberculosis in northern Taiwan. Chronic Disease Control News. 1990;2;12-14. March F, Coll P, Guerrero RA, Busquets E, Cayla JA, Prats G, et al. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS 2000;14:525-35. Martinez AN, Rhee JT, Small PM, et al. Sex difference in the epidemiology of tuberculosis in San Francisco. Int J Tuberc Lung Dis 2000;4:26-31. Murray M. Sampling bias in the molecular epidemiology of tuberculosis. Emerging Infectious Diseases 2002;8:363-9. Murray MB, Alland DA. Methodological problems in the molecular epidemiology of tuberculosis. American Journal of Epidemiology 2002;155:565-71. Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bulletin of World Health Organization 2002;80:477-482. Nardell E, Mclnnis B, Thomas B, Weidhaas S. Exogenous reinfection with tuberculosis in a shelter for the homeless. New England Journal of Medicine 1986;315:1570-4. Nettleman MD. Multidrug-resistant tuberculosis – News from the front. JAMA. 2005;293:2788-2790. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998;338:1641-9. Pfyffer GE, Strassle A, Rose N, Wirth R, Brandli O, Shang H, et al. Transmission of tuberculosis in the metropolitan area of Zurich: a 3 year survey based on DNA fingerprinting. European Respiratory Journal 1998;11:804-8. Pineda-Garcia L, Ferrera A, Hoffner SE. DNA fingerprinting of Mycobacterium tuberculosis strains from patients with pulmonary tuberculosis in Honduras. Journal of Clinical Microbiology 1997;35:2393-7. Rajbhandary SS, Marks SM, Bock NN. Cost of patients hospitalized for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2004;8:1012-1016. Razanamparany VR, Menard D, et al. Extrapulmonary and pulmonary tuberculosis in Antananarivo(Madagascar): high clustering rate in female patients. Journal of Clinical Microbiology 2002;40:3964-3969. Resolution WHA 44.8. Tuberculosis control programme. In: Handbook of resolutions and decisions of the World Health Assembly and the Executive Board. Vol Ⅲ, 3rd edition (1985-1992) Geneva, World Health Organization, 1993 (WHA/1991/REC/1) Rieder HL, Snider DE. Tuberculosis and the acquired immunodeficiency syndrome. Chest 1986;90:469-70. Rudy M, Balabanova Y, Graham C, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Smara Region, Russia. Thorax 2005;60:130-135. Salihu HM, Naik E, et al. Tuberculosis in North Carolina: Trends across two decades, 1980-1999. Emerging Infectious Diseases 2001;7:570-574. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50. Shafer RW, Singh SP, Larkin C, Small PM. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient. Tubercle and Lung Disease 1995;76:575-7. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods in the 1990s. New England Journal of Medicine 1994;330:1703-9. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. New England Journal of Medicine 1993;328:1137-44. Styblo K, Bumgarner JR. Tuberculosis can be controlled with existing technologies: evidence. Tuberc Surveill Res Unit Prog Rep. 1991;2:60-72. Styblo K. Epidemiology of Tuberculosis. 2nd ed. The Hague: Royal Netherlands Tuberculosis Association; 1991. Styblo K. Epidemiology of tuberculosis. Jena: Gustav Fischer Verlag; 1984. Suarez PG, Floyd K, Portocarreo J, et al. Feasibility and cost-effectiveness of standardized second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. The Lancet. 2002;359:1980-1989. Su WJ, Lee PY, Yu KW, Perng RP. Drug resistance of Mycobacterium tuberculosis isolated from patients at a medical center in Taiwan. Zhonghua Yi Za Zhi (Taipei) 1997;60:21-7. Suo J, Yu MC, Lee CN, et al: Treatment of multidrug-resistant tuberculosis in Taiwan. Chemotherapy 1996;42(suppl 3):20-3. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1975;19:1-63. Sutherland I, Svandova E, Radhakrishna S. The development of clinical tuberculosis following infection with tubercle bacilli. Tuberc 1982;63:255-268. Tuberculosis Control Committee, Taiwan Provincial Health Department: Taiwan Tuberculosis Control Program. Annual Report, 1965. United Nations Statistics Division. Millennium indicators database. Available at: http://unstats.un.org/unsd/mi/mi_goals.asp. Accessed November 22, 2004. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. New England Journal of Medicine 1999;341:1174-9. van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. Journal of Clinical Microbiology 1991;29:2578-86. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. Journal of Clinical Microbiology 1995;33:3234-8. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect. 1997;119:183-201. Wang PD, Lin RS. Drug-resistant tuberculosis in Taipei, 1996-1999. Am J Infect Contr 2001;29:41-7. Warren R, Richardson M, van der Spuy G, Victor T, Sampson S, Beyers N, et al. DNA fingerprinting and molecular epidemiology of tuberculosis: use and interpretation in an epidemic setting. Electrophoresis 1999;20:1807-12. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330:1179-1184. Wikinson D, Pillay M, Crump J, Lombard C, Davies GR, Sturm AW, et al. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Tropical Medicine and International Health 1997;2:747-53. World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001;5:213-215. World Health Organization. An Expanded DOTS Framework for Effective Tuberculosis Control. Geneva, Switzerland: WHO; 2002. WHO/CDS/TB/2002. 297. World Health Organization. An expanded framework for effective tuberculosis control. Int J Tuberc Lung Dis. 2002;6:378-388. World Health Organization. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997. Geneva: World Health Organization, 1997 (WHO/TB/97.229). World Health Organization. Anti-tuberculosis drug resistance in the world. Geneva, Switzerland: WHO/CDS/TB/2000.278. World Health Organization. Anti-tuberculosis drug resistance in the world, report number 3. Geneva, Switzerland: World Health Organization; 2005. World Health Organization. Forty-fourth World Health Assembly, Resolutions and Decisions. Geneva, Switzerland: World Health Organization; 1991. WHA44/1991/REC/1. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva, Switzerland: World Health Organization; 2005. WHO/HTM/TB/2005.349. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report 2002. Geneva, Switzerland: WHO/CDS/TB/2002.295. World Health Organization: Anti-tuberculosis drug resistance in the world. Report no. 2: Prevalence and trends. WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 2000 (WHO/CDS/TB/2000.278). World Health Organization. Global tuberculosis control: WHO Report 2000. Geneva, Switzerland: WHO/CDS/TB/2000.275. World Health Organization. Global tuberculosis control: WHO Report 1998. Geneva, Switzerland: WHO/TB/98-237. Wu YT. Primary drug resistance of Mycobacteria tuberculosis in Taiwan. J Formos Med Assoc 1973;72:135-142. Vynnycky E, Nagelkerke N, Borgdorff MW, van Soolingen D, van Embden JD. The effect of age and study duration on the relationship between “clustering” of DNA fingerprint patterns and the proportion of tuberculosis disease attributable to recent transmission. Epidemiology and Infection 2001;126:43-62. Yang ZH, Rendon A, Flores A, Medina R, Ijaz K, Llaca J, et al. A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico. International Journal of Tuberculosis and Lung Disease 2000;5:313-20. Yeh YP, Chang HJ, et al. Incidence of tuberculosis in Mountain areas and surrounding townships: dose-response relationship by geographic analysis. Ann Epidemiol in press. Yu MC, Bai KJ, Chang JH, Lee CN. Tuberculosis incidence and mortality in aboriginal areas of Taiwan, 1997-2001. J Formos Med Assoc 2004;103:817-23. Yu MC, Suo J, Chiang CY, Bai KJ, Lin TP, Luh KT. Initial drug resistance of Mycobacterium tuberculosis in Taiwan. J Formos Med Assoc 1997;96:890-4. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35844 | - |
| dc.description.abstract | 背景
雖然在西方國家已普遍使用DNA fingerprinting來預測結核病是否為新近感染結核病,但在高盛行率的國家,則受限於價格及潛在病灶之再活化與新近之再感染間錯綜複雜的關係而無法廣泛使用。 目的 因此本研究嘗試以另一種方法僅仰賴例行性的流行病學調查資料來研討: (1)評估結核病發生病例的性別差異、時間趨勢和地理分布的差異性 (2)發展指標病例分析法來估計不同地區在指標病例發生後時間間隔的分佈 (3)以(1)及(2)得到的實證結果來評估結核病的新近感染與潛在病灶的再活化 (4)根據(1)~(3)所得到的結果提出結核病在不同鄉鎮間的可能傳染模式 材料與方法 資料來源為彰化縣自1991年至2002年間的結核病登記資料,共有9673例結核病發生病例。首先計算年齡性別標準化罹病率(SMR),並使用SMR將彰化縣26個鄉鎮分為三個區域:高危險區域、中危險區域、低危險區域。並利用地理區域及Poisson回歸模式來分析年齡別的曲線及時間趨勢。 此外本研究發展指標病例分析法依各種指標病例的可能組合來產生模擬資料,並與實際指標病例發生後時間間隔的分佈來進行比較,以估計第二個病例的平均有效再生數。並合併使用Cox回歸模式來區分新近感染與潛在病灶之再活化,並檢測與新近感染相關的傳染模式。 結果 依地理區域分析來看,我們發現有二處高發生率的聚集分佈,ㄧ呈西南方向分佈,由二林鎮到大林鄉,另ㄧ處則集中在彰化縣的南部三鄉鎮。除了一些鄉鎮如員林鎮、大林鄉、大城鄉,其餘鄉鎮男女性發生率成互補的關係,即若男性發生率高,則女性發生率低,反之亦然。 在時間趨勢的分析方面,在調整年齡、性別、鄉鎮之後,結核病的年發生率有6%的增加。此外,並發現年齡、性別及年代三者間對結核病的發生率有顯著的交互作用。 在指標病例的分析方面,產生第二個病例的有效再生數在所有鄉鎮均大於1。我們並發現位於二林的彰化監獄的病例,有最短的時間間隔(指標病例至產生第二例的時間間隔),平均僅6.82個月。平均年有效再生數在所有年齡層為1.68,在15-24歲、25-34歲、35-44歲、45-44歲、55-64歲及65歲以上族群分別為1.78、1.38、1.90、1.63、2.15及1.74。在高危險地區,在埔鹽鄉的年有效再生數為1.29,其次為二林鎮的1.27。若以指標病例的年齡分層,則發現平均有效再生數在25-34歲為最大,為1.52。若結合Cox回歸分析,可發現回歸係數在各年齡層均不同。使用相同的研究方法,則可以發現在任二個鄰近的鄉鎮有單向或雙向的新近傳染發生。 結論 本研究提出ㄧ個系統性的方法來評估潛在病灶之再活化與新近感染相關的時間趨勢、性別差異及年齡差異。我們發現新近感染似乎發生在男性或所有年齡層而非西方國家所觀察到的主要發生在年輕族群。由方法學的觀點來看,指標病例分析法可以和DNA fingerprinting互補,以利偵測新近感染的發生。 | zh_TW |
| dc.description.abstract | Abstract
Background Despite the widespread use of DNA fingerprinting in detecting recent infection in Western countries, the feasibility of applying this technique to the country with high prevalence of TB may be limited to cost and intricate relationship between re-activation and recent infection. Aims We provided an alternative approach merely based on routine surveillance of epidemiological data (1) to assess sexual difference, time trend, geographic variation in TB incident cases; (2) to develop an index-case approach to estimate the distribution of time interval since occurrence of index cases by geographic area; (3) to assess recent infection or re-activation using the empirical evidence from (1) and (2); (4) to propose possible transmission routes across townships based on (1)-(3). Methods The epidemiological data on a total of 9,673 TB incident cases in ChangHua, one of middle counties in Taiwan, between 1991 and 2002 were collected. Age-sex adjusted Standard Morbidity Ratio (SMR) was first applied to categorizing 26 townships into three classes: high-risk area, moderate-risk area, and low-risk area. Age-specific and time-trend by three risk areas were analyzed by graphics or Poisson regression model. An index-case approach by generating data with every possible combination of index case was developed to fit the distribution of time-interval since occurrence of index cases and to estimate average number of reproductive number of secondary cases. This approach together with Cox regression model was applied to distinct recent infection form re-activation and to identify possible transmission related to recent infection. Results In geographic analysis, we identified two high rate areas, one extending southwestward from “二林鎮“ to “大村鄉“ and the other clustering in three townships of southern ChangHua. Except some townships such as “員林鎮”,”大村鄉”,”大城鄉“, there was a reciprocal relationship between male and female, high incidence rate in male but low in female and vice versa. In time trend analysis, there was a 6% (6%-7%) increase in TB incidence rate from 1991 to 2002 after controlling for age, gender, and townships. Three-way interactions with respect to age, gender, and calendar year were demonstrated. In index-case analysis, average reproductive number of secondary TB cases in all townships was larger than 1. We found TB cases from prison located in “二林鎮” had the shortest average interval time for reproducing secondary cases, approximately 6.82 month. Annual reproductive number was approximately 1.68 for all age groups, 1.78 for age 15-24, 1.38 for age 25-34, 1.90 for age 35-44, 1.63 for age 45-54, 2.15 for age 55-64, and 1.74 for age 65+ . Of high-risk township, annual reproductive number was approximately 1.29 in “埔鹽鄉“ followed by 1.27 in “二林鎮” and so on. By the stratification of age of index cases, it was found that average reproductive number, 1.52, was the largest in age 25-34 years. By the application of index-case approach coupled with Cox regression, we found the regression coefficients vary with age groups. Using the similar approach, the possible one-way or two-way recent infections in any two adjacent areas were proposed after taking back and forth between two areas into account. Conclusions The present study developed a systematic method to assess time trend, sexual difference, and age variation with respect to re-activation or re-infection. Our findings suggest newly infection may be involved in male and all age groups unlike only seen in the young subjects in Western countries. For the methodological viewpoint, our index-case approach method may complement DNA fingerprinting to detect newly infection. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T07:13:14Z (GMT). No. of bitstreams: 1 ntu-94-P92846004-1.pdf: 1167204 bytes, checksum: fb5f690f7a5356883bd29e4c57d02b01 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | Table of Contents
Abstract……………………………………………………………….. 6 中文摘要……………………………………………………………… 9 Chapter 1 Introduction………………………………………………… 11 Chapter 2 Literature Review………………………………………....... 13 2.1 Global burden and trend of incidence of tuberculosis………….. 13 2.2 The Impact of DOTS on Epidemiological Trends……………… 15 2.3 Tuberculosis in Taiwan………………………………………..... 17 2.4 Sex difference and Tuberculosis………………………………... 19 2.5 Drug Resistance of Tuberculosis……………………………….. 21 2.6 Natural history of tuberculosis…………………………………. 25 2.7 Exogenous Reinfection…………………………………………. 27 2.8 Recent Infection………………………………………………… 32 2.9 Summary of Reviews…………………………………………… 34 Chapter 3 Material and Methods……………………………………… 36 3.1 Data Sources ………………………………………………….... 36 3-2 Study Framework……………………………………………..... 36 3.3 Standard Morbidity Ratio (SMR)………………………………. 36 3.4 Index-Case Approach…………………………………………… 36 3.5 Risk of Reproducing Secondary cases by Age…………………. 39 Chapter 4 Results……………………………………………………… 41 4.1 Distribution of TB in ChangHua County………………………. 41 4.2 Age-specific Incident Curve by Grade of Incidence Rate…....... 42 4-3 Time Trend of TB in ChangHua County………………………. 42 4-4 Time Interval Using Index-Case Approach……………………. 43 4-5 Average Reproductive Number Using Index-Case Approach…. 44 4-6 Recent Infection Transmission………………………………… 45 Chapter 5 Discussion…………………………………………………. 46 Reference……………………………………………………………… 50 List of Tables Table 1-1. Incidence Rate of 1999-2003 by county (DOH report)…………………………......... 65 Table 2-1 Primary anti-tuberculosis drug resistances in Taiwan, 1960-2002……………………. 66 Table 3-1 The distribution of TB cases by calendar year and gender……………………………. 67 Table 4-1. Estimated Results of Relative Risk by using Poisson Regression Model……………. 68 Table 4-2. Estimated Results of Relative Risk by using Three-way Poisson Regression Model... 69 Table 4-3(a). Relative Risk of Area, adjusted by Year , Male Aged 0-14……………………….. 70 Table 4-3(b). Relative Risk of Area, adjusted by Year, Male Aged 15-24………………………. 71 Table 4-3(c). Relative Risk of Area, adjusted by Year, Male Aged 25-34………………………. 72 Table 4-3(d).Relative Risk of Area, adjusted by Year , Male Aged 35-44………………………. 73 Table 4-3(e). Relative Risk of Area, adjusted by Year , Male Aged 45-54……………………… 74 Table 4-3(f). Relative Risk of Area, adjusted by Year , Male Aged 55-64………………………. 75 Table 4-3(g). Relative Risk of Area, adjusted by Year , Male Aged over 65……………………. 76 Table 4-3(h). Relative Risk of Area, adjusted by Year, Female Aged 0-14……………………… 77 Table 4-3(i). Relative Risk of Area, adjusted by Year , Female Aged 15-24……………………. 78 Table 4-3(j). Relative Risk of Area, adjusted by Year , Female Aged 25-34……………………. 79 Table 4-3(k). Relative Risk of Area, adjusted by Year , Female Aged 35-44…………………… 80 Table 4-3(l). Relative Risk of Area, adjusted by Year , Female Aged 45-54……………………. 81 Table 4-3(m). Relative Risk of Area, adjusted by Year , Female Aged 55-64…………………... 82 Table 4-3(n). Relative Risk of Area, adjusted by Year , Female Aged over 65…………………. 83 Table 4-4. Year Increasing Rate, adjusted by age and .gender………………………………….. 84 Table 4-5(a). Mean time interval between index-case and secondary case……………………… 85 Table 4-5(b). Mean time interval between index-case and secondary case aged 0-14…………... 86 Table 4-5(c). Mean time interval between index-case and secondary case age15-24…………… 87 Table 4-5(d). Mean time interval between index-case and secondary case aged 15-24…………. 88 Table 4-5(e). Mean time interval between index-case and secondary case aged 35-44…………. 89 Table 4-5(f). Mean time interval between index-case and secondary case aged 45-54………….. 90 Table 4-5(g). Mean time interval between index-case and secondary case aged 55-64…………. 91 Table 4-5(h) Mean time interval between index-case and secondary case aged over 65………... 92 Table 4-6(a). Transmission across age groups using an index approach coupled with Cox Regression Model……………………………….………………………………. 93 Table 4-6(b). Transmission across age groups using an index approach coupled with Cox Regression Model………………………………………………………………… 94 Table 4-6(c). Transmission across age groups using an index approach coupled with Cox Regression Model………………………………………………………………….. 95 List of Figures Figure 3.1 Study Procedure for the diagnosis of Endemic TB model…………………………… 96 Figure 4-1. Time trends in incidence rate……………………………………………………….. 97 Figure 4-2. Distribution of SMR by geographic areas of Chang-Hua County………………….. 98 Figure 4-3. Age-gender-adjusted SMR by geographic areas of Chang-Hua County (Male)……. 99 Figure 4-3. Age-gender-adjusted SMR by geographic areas of Chang-Hua County (Female)….. 100 Figure 4-4. Age-specific incidence rate of TB by gender……………………………………….. 101 Figure 4-5. Age-specific incidence rate by SMR grade…………………………………………. 102 Figure 4-6. Age-specific incidence rate by SMR grades (Male)………………............................ 103 Figure 4-6. Age-specific incidence rate by SMR grades (Female)………………........................ 103 Figure 4-7(a)-(z). Time trend of TB incident rates of townships, Chang-Hua County (High)….. 104 Figure 4-7(a)-(z). Time trend of TB incident rates of townships, Chang-Hua County (Middle)... 106 Figure 4-7(a)-(z). Time trend of TB incident rates of townships, Chang-Hua County (Low) ….. 108 Figure 4-8. Frequencies of time interval by townships, Male, all………………………………. 110 Figure 4-9 (a) Frequencies of time interval by townships, Male, aged 0-14……………………. 111 Figure 4-9 (b) Frequencies of time interval by townships, Male, aged 15-24…………………… 112 Figure 4-9 (c) Frequencies of time interval by townships, Male, aged 25-34…………………… 113 Figure 4-9 (d) Frequencies of time interval by townships, Male, aged 35-44…………………… 114 Figure 4-9 (e) Frequencies of time interval by townships, Male, aged 45-54…………………… 115 Figure 4-9 (f) Frequencies of time interval by townships, Male, aged 55-64……........................ 116 Figure 4-9 (g) Frequencies of time interval by townships, Male, aged over 65…........................ 117 Figure 4-10. Frequencies of time interval by townships, Female, all Age………........................ 118 Figure 4-11(a).Frequencies of time interval by townships, Female, aged 0-14………………….. 119 Figure 4-11(b).Frequencies of time interval by townships, Female, aged 15-24………………... 120 Figure 4-11(c).Frequencies of time interval by townships, Female, aged 25-34………………… 121 Figure 4-11(d).Frequencies of time interval by townships, Female, aged 35-44………………... 122 Figure 4-11(e).Frequencies of time interval by townships, Female, aged 45-54………………… 123 Figure 4-11(f).Frequencies of time interval by townships, Female, aged 55-64………………… 124 Figure 4-11(g).Frequencies of time interval by townships, Female, aged over 65........................ 125 Figure 4-12. Possible one-way or two-way recent infections in two adjacent areas, Male……. 126 Figure 4-13. Possible one-way or two-way recent infections in two adjacent areas, Female….. 127 | |
| dc.language.iso | en | |
| dc.subject | 新近感染 | zh_TW |
| dc.subject | 再復發 | zh_TW |
| dc.subject | 結核病 | zh_TW |
| dc.subject | recent infection | en |
| dc.subject | reactivation | en |
| dc.subject | tuberculosis | en |
| dc.title | 平地鄉結核病新近感染與再復發之探討-以彰化縣為例 | zh_TW |
| dc.title | Recent Infection and Reactivation of Tuberculosis-Illustration with Chang-Hua County | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 葉彥伯,索任,張淑惠,郭旭崧 | |
| dc.subject.keyword | 結核病,新近感染,再復發, | zh_TW |
| dc.subject.keyword | tuberculosis,recent infection,reactivation, | en |
| dc.relation.page | 127 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-07-27 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 預防醫學研究所 | zh_TW |
| 顯示於系所單位: | 流行病學與預防醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 未授權公開取用 | 1.14 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
